INNOVACAP Innova Captab Q3 FY25 results (Oct–Dec 2024) and concall
Innova Captab reported healthy growth in Q3 FY25, driven by strong performance across its CDMO and international generic businesses, despite a slight decline in Sharon's revenue due to deferred orders. The company achieved significant profitability improvements, with PAT growing over 36% YoY. A major highlight was the commencement of commercial production at the new Jammu facility, which is expected to be a key growth driver, contributing substantial incremental revenue and margin benefits in the coming years.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 318 | 316 |
| EBITDA | 50 | 47 |
| Net profit | 35 | 34 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
